Lista de obras - Azhar Ansari - Dominio Público Uruguay

Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).

artículo científico publicado en 2004

Autologous stem cell transplantation in severe treatment-resistant Crohn's disease: long-term follow-up of UK patients treated on compassionate basis

artículo científico publicado en 2014

Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone.

artículo científico publicado en 2017

Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease--proceedings of the first Thiopurine Task Force meeting.

artículo científico publicado en 2010

Editorial: an argument for low-dose thiopurine allopurinol combination use as first-line therapy in inflammatory bowel disease

artículo científico publicado en 2018

Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom

scientific article published on 11 September 2020

Experience with the use of low-dose methotrexate for inflammatory bowel disease

artículo científico publicado en 2004

Flare to care - future management of long-term conditions

scientific article published on 01 March 2019

Further experience with the use of 6-thioguanine in patients with Crohn's disease

artículo científico publicado en 2008

Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency.

artículo científico publicado en 2002

Genetic determinants of the pre- and post-azathioprine therapy thiopurine methyltransferase activity phenotype

artículo científico publicado en 2004

Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and Caucasians

artículo científico publicado en 2003

Genetic variation in the MTHFR gene influences thiopurine methyltransferase activity

artículo científico publicado en 2005

Influence of xanthine oxidase on thiopurine metabolism in Crohn's disease

artículo científico publicado en 2008

Liquid chromatography-mass spectrometry for measuring deoxythioguanosine in DNA from thiopurine-treated patients

artículo científico publicado en 2016

Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study

artículo científico publicado en 2016

Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease

artículo científico publicado en 2008

Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease

artículo científico publicado en 2009

Mutation in the ITPA gene predicts intolerance to azathioprine

artículo científico publicado en 2004

Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease

artículo científico publicado en 2009

PROCESS AND SYSTEMS: A population-based model of care for people with inflammatory bowel disease - patient-reported outcomes

Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease

artículo científico publicado en 2008

Splitting a therapeutic dose of thioguanine may avoid liver toxicity and be an efficacious treatment for severe inflammatory bowel disease: a 2-center observational cohort study

artículo científico publicado en 2014

Successful Pregnancies with Thiopurine-Allopurinol Co-Therapy for Inflammatory Bowel Disease

artículo científico publicado en 2015

The continuous rediscovery and the benefit-risk ratio of thioguanine, a comprehensive review

artículo científico publicado en 2020

Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease

artículo científico publicado en 2002

Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?

artículo científico publicado en 2004

Typing TPMT and ITPase to detect azathioprine toxicity

artículo científico publicado en 2006

Lista de obras de Azhar Ansari

Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).

Autologous stem cell transplantation in severe treatment-resistant Crohn's disease: long-term follow-up of UK patients treated on compassionate basis

Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone.

Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease--proceedings of the first Thiopurine Task Force meeting.

Editorial: an argument for low-dose thiopurine allopurinol combination use as first-line therapy in inflammatory bowel disease

Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom

Experience with the use of low-dose methotrexate for inflammatory bowel disease

Flare to care - future management of long-term conditions

Further experience with the use of 6-thioguanine in patients with Crohn's disease

Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency.

Genetic determinants of the pre- and post-azathioprine therapy thiopurine methyltransferase activity phenotype

Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and Caucasians

Genetic variation in the MTHFR gene influences thiopurine methyltransferase activity

Influence of xanthine oxidase on thiopurine metabolism in Crohn's disease

Liquid chromatography-mass spectrometry for measuring deoxythioguanosine in DNA from thiopurine-treated patients

Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study

Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease

Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease

Mutation in the ITPA gene predicts intolerance to azathioprine

Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease

PROCESS AND SYSTEMS: A population-based model of care for people with inflammatory bowel disease - patient-reported outcomes

Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease

Splitting a therapeutic dose of thioguanine may avoid liver toxicity and be an efficacious treatment for severe inflammatory bowel disease: a 2-center observational cohort study

Successful Pregnancies with Thiopurine-Allopurinol Co-Therapy for Inflammatory Bowel Disease

The continuous rediscovery and the benefit-risk ratio of thioguanine, a comprehensive review

Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease

Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?

Typing TPMT and ITPase to detect azathioprine toxicity